<DOC>
	<DOCNO>NCT00236210</DOCNO>
	<brief_summary>VIP demonstration project goal decrease modifiable risk factor high risk vascular event heart attack stroke develop vascular disease . Introduced study , VIP compare whether significant reduction modifiable vascular risk factor among patient involve personalized direct program versus provide standard care physician . Health care provider work collaboratively 'VIP Team ' improve participant ' vascular health .</brief_summary>
	<brief_title>A Randomized Controlled Trial Novel Community-based Primary Secondary Cardiovascular Prevention Program</brief_title>
	<detailed_description>This Northern Ontario , community-based demonstration project multi-disciplinary , primary care provider-based collaboration . The goal project : 1 . Decrease modifiable risk factor primary care patient risk vascular disease Algoma District ; 2 . Increase collaboration health care provider family physician , pharmacist , physiotherapist , dietitian nurse community ; 3 . Increase participation patient family decision-making , self-care , adherence agreed-upon management plan ; 4 . Improve patient access care , clinical outcome satisfaction ; 5 . Provide business case practical , sustainable generalizable model primary care vascular disease community . The Group Health Centre , multi-disciplinary , not-for-profit community-based health organization 56,000 rostered patient , lead project . However , Sault Ste Marie community patient eligible join Vascular Intervention Program ( VIP ) . This program three key component : registry VIP patient audit , recall feedback ; use novel ACTION score template , optional use VIPNet , personalize patient record tool provide secure web access optimize quality continuity care . The VIP project aim empower patient increase collaboration among primary health care team . Patients vascular risk factor eligible VIP . The VIP project demonstration project duplicate exist GHC chronic disease management program ( 1 ) VIP offer eligible community patient , GHC enrollees ; ( 2 ) VIP integrate patient vascular risk , pre-defined condition ; ( 3 ) novel collaborative tool ACTION template VIPNet website pilot ; ( 4 ) explicit patient-centred decision make drive process . The development evaluation VIP demonstration project unique step evolution primary care chronic disease management Sault Ste Marie , rest province .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Men &gt; 30 year age Women &gt; 40 year age History vascular disease ( define Study Design , page 8 ) Framingham Risk Score &gt; /= 12 % Capable give informed consent Ability willingness complete questionnaire study procedures do Willingness belong either intervention standard care arm FRS &lt; 12 % ( low risk ) enrol cohort arm ( randomize . Followup study end . ) Any condition prevent patient participate complete study Unable come Group Health Centre appointments Any factor likely limit protocol compliance Unwilling permit VIP staff contact primary physician communicate information study participant 's data treatment assignment Previous randomization study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Vascular Intervention Program</keyword>
	<keyword>Vascular Disease</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Lifestyle Modification</keyword>
	<keyword>Modifiable Risk Factors</keyword>
</DOC>